General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Merck(MODEST), AMGEN(MODEST), Pfizer(MODEST), sanofi-aventis/regeneron(MODEST), Eli Lilly and Company(MODEST), Boehringer Ingelheim Pharmaceuticals, Inc(MODEST), Bayer(MODEST), Esperion(MODEST), Novartis Corporation(MODEST)